Corthorn Health
Clinical and toxicology laboratory in Chile providing occupational toxicology, clinical analyses and environmental surveillance. Services include workplace drug and alcohol testing, therapeutic drug monitoring, biomarker assays (cortisol in hair and urine), specialized occupational exposure assays (e.g., cyclophosphamide in urine), wastewater-based epidemiology, rapid screening (saliva, fingerprint) with laboratory confirmation, and participation in regional surveillance projects and international conferences. Operates under accredited laboratory quality systems.
Industries
Nr. of Employees
small (1-50)
Corthorn Health
Avda. del Parque 4980 of. 136-137, Huechuraba, Chile
Services
Programmatic testing for pre-employment and routine workplace screening with laboratory confirmation and reporting for occupational risk management.
Diagnostic and monitoring tests for employee health surveillance, including cortisol assays and exposure monitoring for hazardous agents.
Laboratory quantification of drugs and biomarkers to guide clinical treatment and adherence monitoring using chromatographic-mass spectrometric methods.
Consultancy and support for developing workplace alcohol and drug policies, legal case preparation and contestation of test results.
Design and execution of wastewater sampling campaigns and laboratory analysis to detect drugs, metabolites and markers for community-level surveillance and research.
Targeted assays for occupational exposure monitoring (for example, cytotoxic agents) and cortisol measurement in hair and urine for health and regulatory monitoring.
Programmatic testing for pre-employment and routine workplace screening with laboratory confirmation and reporting for occupational risk management.
Diagnostic and monitoring tests for employee health surveillance, including cortisol assays and exposure monitoring for hazardous agents.
Laboratory quantification of drugs and biomarkers to guide clinical treatment and adherence monitoring using chromatographic-mass spectrometric methods.
Consultancy and support for developing workplace alcohol and drug policies, legal case preparation and contestation of test results.
Design and execution of wastewater sampling campaigns and laboratory analysis to detect drugs, metabolites and markers for community-level surveillance and research.
Targeted assays for occupational exposure monitoring (for example, cytotoxic agents) and cortisol measurement in hair and urine for health and regulatory monitoring.
Expertise Areas
- Clinical toxicology
- Occupational health monitoring
- Therapeutic drug monitoring
- Wastewater-based epidemiology
Key Technologies
- Liquid chromatography–mass spectrometry (LC-MS/MS)
- Mass spectrometry
- Liquid chromatography
- Rapid immunoassay screening (point-of-care saliva tests)
News & Updates
Regional dialogue convening public and private sector stakeholders to discuss implementation of concrete prevention strategies related to mobility and public safety.
Description of a regional wastewater surveillance initiative using LC-MS/MS to detect drugs, metabolites and markers for public health monitoring.
Technical analysis of a wastewater monitoring program covering multiple communes of the Biobío region, including methodology, sampling design and substances analyzed.
Report showing an increase in ketamine levels detected in wastewater monitoring between 2023 and 2024, supporting public health surveillance findings.
Presentation of wastewater-based epidemiology research at an international WBE conference.
Report on a regional convening addressing prevention strategies and multisector collaboration.
Regional dialogue convening public and private sector stakeholders to discuss implementation of concrete prevention strategies related to mobility and public safety.
Description of a regional wastewater surveillance initiative using LC-MS/MS to detect drugs, metabolites and markers for public health monitoring.
Technical analysis of a wastewater monitoring program covering multiple communes of the Biobío region, including methodology, sampling design and substances analyzed.
Report showing an increase in ketamine levels detected in wastewater monitoring between 2023 and 2024, supporting public health surveillance findings.
Presentation of wastewater-based epidemiology research at an international WBE conference.
Report on a regional convening addressing prevention strategies and multisector collaboration.